Cargando…
Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy
Low-level laser therapy has been widely used in treating many conditions, including oral mucositis. The purpose of this study was to evaluate the occurrence of oral mucositis in patients undergoing antineoplastic therapy submitted to preventive and therapeutic treatment with low-level laser therapy....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977129/ https://www.ncbi.nlm.nih.gov/pubmed/29695071 http://dx.doi.org/10.3390/jcm7050090 |
_version_ | 1783327311453487104 |
---|---|
author | Leite Cavalcanti, Alessandro José de Macêdo, Dário Suely Barros Dantas, Fernanda dos Santos Menezes, Karla Filipe Bezerra Silva, Diego Alves de Melo Junior, William Fabia Cabral Cavalcanti, Alidianne |
author_facet | Leite Cavalcanti, Alessandro José de Macêdo, Dário Suely Barros Dantas, Fernanda dos Santos Menezes, Karla Filipe Bezerra Silva, Diego Alves de Melo Junior, William Fabia Cabral Cavalcanti, Alidianne |
author_sort | Leite Cavalcanti, Alessandro |
collection | PubMed |
description | Low-level laser therapy has been widely used in treating many conditions, including oral mucositis. The purpose of this study was to evaluate the occurrence of oral mucositis in patients undergoing antineoplastic therapy submitted to preventive and therapeutic treatment with low-level laser therapy. This cross-sectional study was carried out with 51 children and adolescents of both sexes with malignant neoplasias who developed oral mucositis and underwent low-level laser therapy. Data were collected on sex, age, type and degree of neoplasia, region affected, and remission time. 64.7% of the patients were male and were between 3 and 6 years of age (39.2%). Acute lymphoid leukemia was the most frequent neoplasm (37.3%). Regarding the maximum oral mucositis, grade 2 (41.2%) was predominant, with jugal mucosa (29.9%) and tongue (17.7%) being the most affected regions. The majority of cases presented lesion remission time between 4 and 7 days (44.0%). Most patients were young, male, and diagnosed with acute lymphoid leukemia. Predominance of grade 2 oral mucositis was observed, with jugal mucosa and tongue being the most affected regions, with the majority of cases presenting lesion remission time between 4 and 7 days. Low-level laser therapy has been shown to be an essential therapy in the prevention and treatment of these lesions, since it is a non-invasive and low-cost method. |
format | Online Article Text |
id | pubmed-5977129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59771292018-05-31 Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy Leite Cavalcanti, Alessandro José de Macêdo, Dário Suely Barros Dantas, Fernanda dos Santos Menezes, Karla Filipe Bezerra Silva, Diego Alves de Melo Junior, William Fabia Cabral Cavalcanti, Alidianne J Clin Med Article Low-level laser therapy has been widely used in treating many conditions, including oral mucositis. The purpose of this study was to evaluate the occurrence of oral mucositis in patients undergoing antineoplastic therapy submitted to preventive and therapeutic treatment with low-level laser therapy. This cross-sectional study was carried out with 51 children and adolescents of both sexes with malignant neoplasias who developed oral mucositis and underwent low-level laser therapy. Data were collected on sex, age, type and degree of neoplasia, region affected, and remission time. 64.7% of the patients were male and were between 3 and 6 years of age (39.2%). Acute lymphoid leukemia was the most frequent neoplasm (37.3%). Regarding the maximum oral mucositis, grade 2 (41.2%) was predominant, with jugal mucosa (29.9%) and tongue (17.7%) being the most affected regions. The majority of cases presented lesion remission time between 4 and 7 days (44.0%). Most patients were young, male, and diagnosed with acute lymphoid leukemia. Predominance of grade 2 oral mucositis was observed, with jugal mucosa and tongue being the most affected regions, with the majority of cases presenting lesion remission time between 4 and 7 days. Low-level laser therapy has been shown to be an essential therapy in the prevention and treatment of these lesions, since it is a non-invasive and low-cost method. MDPI 2018-04-24 /pmc/articles/PMC5977129/ /pubmed/29695071 http://dx.doi.org/10.3390/jcm7050090 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leite Cavalcanti, Alessandro José de Macêdo, Dário Suely Barros Dantas, Fernanda dos Santos Menezes, Karla Filipe Bezerra Silva, Diego Alves de Melo Junior, William Fabia Cabral Cavalcanti, Alidianne Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy |
title | Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy |
title_full | Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy |
title_fullStr | Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy |
title_full_unstemmed | Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy |
title_short | Evaluation of Oral Mucositis Occurrence in Oncologic Patients under Antineoplastic Therapy Submitted to the Low-Level Laser Coadjuvant Therapy |
title_sort | evaluation of oral mucositis occurrence in oncologic patients under antineoplastic therapy submitted to the low-level laser coadjuvant therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977129/ https://www.ncbi.nlm.nih.gov/pubmed/29695071 http://dx.doi.org/10.3390/jcm7050090 |
work_keys_str_mv | AT leitecavalcantialessandro evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy AT josedemacedodario evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy AT suelybarrosdantasfernanda evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy AT dossantosmenezeskarla evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy AT filipebezerrasilvadiego evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy AT alvesdemelojuniorwilliam evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy AT fabiacabralcavalcantialidianne evaluationoforalmucositisoccurrenceinoncologicpatientsunderantineoplastictherapysubmittedtothelowlevellasercoadjuvanttherapy |